HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CI

The Cigna Group (S&P 500)

Healthcare — Healthcare Plans

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

None 24 analysts
$301.06
+$10.04 (+3.45%)
Target: $340.92 (13.2%)
Sign in to add CI to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$79.64B
P/E Ratio (TTM)12.76
Forward P/E8.99
EPS (TTM)$23.60
Dividend Yield2.14%
Profit Margin2.26%
Revenue Growth4.60%
ROE16.27%
Debt/Equity72.81
Recommendation None
Analyst Target$340.92
Analysts24
Indexes S&P 500

Technical Indicators

RSI (14)58.2
Beta0.30
SMA 20$289.11
SMA 40$287.04
52-Week High$315.47
52-Week Low$239.51
50-Day Avg$286.36
200-Day Avg$280.16
Avg Volume$1.66M
Volume$1.57M

Performance Analysis

BULLISH

CI shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 81% of its 52-week range.
+ RSI at 58.2 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
+ P/E of 12.8 suggests the stock may be undervalued.
~ Modest revenue growth of 4.6% year-over-year.
~ Wall Street consensus is "none" from 24 analysts.
+ Average analyst target of $340.92 implies 13.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:00 UTC

Back to Screener Export Report